Author:
Reale Antonia,Khong Tiffany,Xu Rong,Chen Maoshan,Mithraprabhu Sridurga,Bingham Nicholas,Spencer Andrew,Greening David W.
Reference139 articles.
1. Barwick BG, Gupta VA, Vertino PM, Boise LH (2019) Cell of origin and genetic alterations in the pathogenesis of multiple myeloma. Front Immunol 10:1121. https://doi.org/10.3389/fimmu.2019.01121
2. Seth S, Zanwar S, Vu L, Kapoor P (2020) Monoclonal gammopathy of undetermined significance: current concepts and future prospects. Curr Hematol Malig Rep. https://doi.org/10.1007/s11899-020-00569-2
3. Rajkumar SV (2016) Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book 35:e418–e423. https://doi.org/10.1200/EDBK_159009
4. Ravi P, Kumar SK, Cerhan JR, Maurer MJ, Dingli D, Ansell SM, Rajkumar SV (2018) Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies. Blood Cancer J 8(3):26. https://doi.org/10.1038/s41408-018-0065-8
5. Spencer AM, P, HA B (2019) Real-world outcome for newly diagnosed patients with functional high-risk myeloma—a myeloma and related diseases registry analysis—abstract. Paper presented at the ASH Orlando, 7–10 dicembre 2019
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献